Seeing Is Believing

Currently out of the existing stock ratings of Nick Nieland, 12 are a BUY (100%).
Analyst Nick Nieland, currently employed at CITI, carries an average stock price target met ratio of 73.33% that have a potential upside of 17.85% achieved within 252 days.
Nick Nieland’s has documented 21 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GLPG, Galapagos NV ADR at 19-Apr-2023.
Analyst best performing recommendations are on EVTC (EVERTEC).
The best stock recommendation documented was for EVTC (EVERTEC) at 3/5/2021. The price target of $38.98 was fulfilled within 41 days with a profit of $3.01 (8.37%) receiving and performance score of 2.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 16-Oct-2020
$33
$4.87 (17.31%)
$32
7 months 12 days ago
(25-Feb-2026)
17/19 (89.47%)
$-1.02 (-3.00%)
59
Hold Since 09-Sep-2024
$40
$11.87 (42.20%)
$24
11 months 16 days ago
(21-Oct-2025)
1/2 (50%)
$8.57 (27.27%)
127
Hold Since 07-Mar-2024
$22
$-6.13 (-21.79%)
$31
1 years 7 months 23 days ago
(14-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Hold Since 13-Oct-2020
$82.77
1 years 8 months 14 days ago
(23-Jan-2025)
1/6 (16.67%)
$-1.59 (-1.88%)
1
Hold Since 14-Oct-2022
1 years 8 months 14 days ago
(23-Jan-2025)
2/6 (33.33%)
$2.78 (6.01%)
28
What Year was the first public recommendation made by Nick Nieland?